Browse > Article

Increases in Doxorubicin Sensitivity and Radioiodide Uptake by Transfecting shMDR and Sodium/Iodide Symporter Gene in Cancer Cells Expressing Multidrug Resistance  

Ahn, Sohn-Joo (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Lee, Yong-Jin (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Lee, You-La (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Choi, Chang-Ik (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Lee, Sang-Woo (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Yoo, Jeong-Soo (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Ahn, Byeong-Cheol (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Lee, In-Kyu (Department of Internal Medicine, School of Medicine, Kyungpook National University)
Lee, Jae-Tae (Department of Nuclear Medicine, School of Medicine, Kyungpook National University)
Publication Information
Nuclear Medicine and Molecular Imaging / v.41, no.3, 2007 , pp. 209-217 More about this Journal
Abstract
Purpose: Multidrug resistance (MDR) of the cancer cells related to mdr1 gene expression can be effectively treated by selective short hairpin RNA for mdr1 gene (shMDR). Sodium/iodide symporter (NIS) gene is well known to have both reporter and therapeutic gene characteristics. We have co-transfected both shMDR and NIS gene into colon cancer cells (HCT15 cell) expressing MDR and Tc-99m sestamibi and I-125 uptake were measured. In addition, cytotoxic effects of doxorubicin and I-131 therapy were also assessed after transfection. Material and Methods: At first, shMDR was transfected with liposome reagent into human embryonic kidney cells (HEK293) and HCT cells. shMDR transfection was confirmed by RT-PCR and western blot analysis. Adenovirus expressing NIS (Ad-NIS) gene and shMDR (Ad-shMDR) were co-transfected with Ad-NIS into HCT15 cells. Forty-eight hours after infection, inhibition of P-gycoprotein (Pgp) function by shMDR was analyzed by a change of Tc-99m sestamibi uptake and doxorubicin cytotoxicity, and functional activity of induced NIS gene expression was assessed with I-125 uptake assay. Results: In HEK293 cells transfected with shMDR, mdr1 mRNA and Pgp protein expressions were down regulated. HCT15 cells infected with 20 MOI of Ad-NIS was higher NIS protein expression than control cells. After transfection of 300 MOI of Ad-shMDR either with or without 10 MOI of Ad-NIS, uptake of Tc-99m sestamibi increased up to 1.5-fold than control cells. HCT15 cells infected with 10 MOI of Ad-NIS showed approximately 25-fold higher I-125 uptake than control cells. Cotransfection of Ad-shMDR and Ad-NIS resulted in enhanced cytotoxic by doxorubicin in HCT15 cells. I-131 treatment on HCT15 cells infected with 20 MOI of Ad-NIS revealed increased cytotoxic effect. Conclusion: Suppression of mdr1 gene expression, retention of Tc-99m sestamibi, enhanced doxorubicin cytotoxicity and increases in I-125 uptake were achieved in MDR expressing cancer cell by co-transfection of shMDR and NIS gene. Dual therapy with doxorubicin and radioiodine after cotransfection shMDR and NIS gene can be used to overcome MDR.
Keywords
short hairpin RNA (shRNA); Multidrug resistance; Sodium/Iodide Symporter; Tc-99m sestamibi; Doxorubicin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Advanced Drug Delivery Reviews 2003;55:3-29   DOI   ScienceOn
2 Hannon GJ. RNA interference. Nature 2002;418:244-51   DOI   ScienceOn
3 Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CYF, et al. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Therapy 2001;8:1524-31   DOI
4 Kamiya H, Tsuchiya H, Yamazaki J, Harashima H. Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv Drug Deliv Rev 2001;52:153-64   DOI   ScienceOn
5 Jekerle V, Wang JH, Scollard DA, Reilly RM, Wiese M, Micheline PM. 99mTc-Sestamibi, A sensitive probe for in vivo imaging of P-glycoprotein inhibition by modulators and mdr1 antisense oligodeoxynucleotides. Mol Imaging Biol 2006;13:60-6
6 Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Gambhir SS. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 2000;6:933-7   DOI   ScienceOn
7 Glasgow JN, Everts M, Curiel DT. Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 2006; 13:830-844   DOI   ScienceOn
8 Yaghoubi SS, Wu L, Liang Q, Toyokuni T, Barrio JR, Gambhir SS, et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Therapy 2001;8:1072-80   DOI
9 Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Therapy 2006;13:60-6   DOI   ScienceOn
10 Matsui Y, Kobayashi N, Nishikawa M, Takakura Y. Sequence-specific suppression of mdr1a/1b expression in mice via RNA interference. Pharmaceutical Research 2005;22:2091-98   DOI   ScienceOn
11 Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, et al. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imagingof gene expression. Mol Ther 2001;4:223-231   DOI   ScienceOn
12 Galina R, Jocelyne P, Sharom FJ. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains. FEBS Journal 2005;272:4924-37   DOI   ScienceOn
13 Lee YJ, Chung JK, Shin JH, Kang JH, Jeong JM, Lee DS et al. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene. Thyroid 2004;14;889-95   DOI   ScienceOn
14 Boland A, Ricard M, Opolon P, Bidart JM, Patrice Y, Filetti S, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000;60:3484-92
15 Stierle V, Laigle A, Jolle B. Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs. Biochemical Pharmacology 2005;70:1424-30   DOI   ScienceOn
16 Kinuya S, Yokoyama K, Fukuoka M, Mori H, Shib K, Watanabe N, et al. Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts. Nucl Med Commun 2005;26:1067-73   DOI   ScienceOn
17 Baron U, Freundlieb S, Gossen M, Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 1995;23:3605-6   DOI   ScienceOn
18 Lee J, Ahn BC. Detection of multidrug resistance using molecular nuclear technique. Korean J Nucl Med 2004;38:180-9   과학기술학회마을
19 Liu Z, Stevenson GD, Barrett HH, Kastis GA, Bettan M, Furenlid LR, et al. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. Nucl Med Commun 2004;25:711-20   DOI   ScienceOn
20 Morettil JL, Hauet1 N, Caglar M, Rebillard O, Burak Z. To use MIBI or not to use MIBI? That is the question when assessing tumour cells. Eur J Nucl Med Mol Imaging 2005;32:836-42   DOI
21 Takara K, Obata Y, Yoshikawa E, Kitada N, Sakaeda T, Ohnishi N, et al. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel. Cancer Chemother Pharmacol 2006;22
22 Levy O, Vieja AD, Carrasco N. The Na+/I- Symporter (NIS): recent advances. J Bioenerg Biomembr 1998;30:195-206   DOI   ScienceOn
23 Lee KH, Kim HK, Paik JY, Matsui T, Choe YS, Choi Y, et al. Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: evaluation with a dual-gene adenovirus vector. J Nucl Med 2005;46:652-7
24 Eytan GD. Mechanism of multidrug resistance in relation to passive membrane permeation. Biomed Pharmacother 2005;59:90-7   DOI   ScienceOn
25 Rebbaa A, Zheng X, Chou PM, Mirkin BL. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 2003;22:2805-11   DOI   ScienceOn
26 Miyagawa M, Anton M, Wagner B, Haubner R, Souvatzoglou M, Gansbacher B, et al. Non-invasive imaging of cardiac transgene expression with PET: comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene. Eur J Nucl Med Mol Imaging 2005;32:1108-14   DOI
27 Chung JK, Kang JH. Translational research using the sodium/iodide symporter in imaging and therapy. Eur J Nucl Med Mol Imaging 2004;31:799-802   DOI   ScienceOn
28 Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999;141:443-57   DOI
29 Wood M, Perrotte P, Onishi E, Harper ME, Dinney C, Pagliaro L, et al. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther 1999;6:367-372   DOI
30 Chung JK. Sodium Iodide Symporter: Its role in nuclear medicine. J Nucl Med 2002;43:1188-200
31 Yoo JA, Chung SY, Seo MR, Kwak DS, Ahn BC, Lee KB, Lee J. Comparison of the uptakes of $^{99m}$Tc-sestamibi and $^{99m}$Tc-tetrofosmin in cancer cell lines expressiong multidrug resistance. Korean J Nucl Med 2003;37:178-89
32 Tjuvajev JG, Joshi A, Callegari J, Lindsley L, Joshi R, Blasberg RG. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia 1999;1:315-20   DOI
33 Bramson J, Hitt M, Gallichan WS, Rosenthal KL, Gauldie J, Graham FL. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum Gene Therapy 1996;7:333-42   DOI   ScienceOn
34 Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Craig CM. Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11   DOI   ScienceOn
35 Young LS, Searle PF, Onion D, Mautner V. Viral gene therapy strategies: from basic science to clinical application. J Pathol 2006;208:299-318   DOI   ScienceOn
36 Mahadevan D, List AF. Targeting the multidrug resistance-1 transporter inAML: molecular regulation and therapeutic strategies. Blood 2004;104:1940-51   DOI   ScienceOn
37 Wu H, Hait W, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-Glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 2003;63:1515-19
38 Burak Z, Moretti JL, Ersoy O, San U, Kantar M, Tamgac F, et al. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance.associated protein and P-glycoprotein expression. J Nucl Med 2003;44: 1394-401